Triasima Portfolio Management Inc. Vertex Pharmaceuticals Inc Transaction History

Triasima Portfolio Management Inc.

$387 Million
Q3 2024

A detailed history of Triasima Portfolio Management Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Triasima Portfolio Management Inc. holds 11,533 shares of VRTX stock, worth $4.74 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares

11,533

Previous 11,505 0.24%

Holding current value

$4.74 Million

Previous $5.39 Million 0.54%

% of portfolio

1.39%

Previous 0.59%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$460.0 - $505.78 $12,880 - $14,161	28 Added 0.24%	11,533 $5.36 Million
Q2 2024 Aug 06, 2024	BUY	$392.81 - $485.53 $1,178 - $1,456	3 Added 0.03%	11,505 $5.39 Million
Q1 2024 Apr 26, 2024	SELL	$407.69 - $446.08 $531,220 - $581,242	-1,303 Reduced 10.18%	11,502 $4.81 Million
Q4 2023 Jan 29, 2024	SELL	$343.0 - $410.68 $763,861 - $914,584	-2,227 Reduced 14.82%	12,805 $5.21 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $372,336 - $399,068	1,101 Added 7.9%	15,032 $5.23 Million
Q2 2023 Aug 07, 2023	BUY	$314.42 - $351.91 $853,650 - $955,435	2,715 Added 24.21%	13,931 $4.9 Million
Q1 2023 Apr 28, 2023	SELL	$283.23 - $323.1 $2.48 Million - $2.83 Million	-8,773 Reduced 43.89%	11,216 $3.53 Million
Q4 2022 Feb 09, 2023	BUY	$285.76 - $321.48 $396,920 - $446,535	1,389 Added 7.47%	19,989 $5.77 Million
Q3 2022 Mar 10, 2023	BUY	$273.83 - $305.53 $2.63 Million - $2.94 Million	9,610 Added 106.9%	18,600 $5.39 Million
Q3 2022 Oct 20, 2022	BUY	$273.83 - $305.53 $2.63 Million - $2.94 Million	9,610 Added 106.9%	18,600 $5.43 Million
Q2 2022 Mar 10, 2023	SELL	$234.96 - $292.55 $2.58 Million - $3.22 Million	-10,999 Reduced 55.03%	8,990 $2.53 Million
Q2 2022 Jul 20, 2022	BUY	$234.96 - $292.55 $2.11 Million - $2.63 Million	8,990 New	8,990 $2.53 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Triasima Portfolio Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Triasima Portfolio Management Inc. with notifications on news.

Account

Triasima Portfolio Management Inc. Vertex Pharmaceuticals Inc Transaction History